Recursos de salud emocional y mental para padres y cuidadores experimentados

You have been on the JM journey for more than a year, possibly much longer, and you are looking for help with your or your child’s emotional and mental health needs. Do you know the warning signs of depression and anxiety? Has your child had a mental/emotional health assessment? Here are some resources for you, your child, and other family members.

At the American College of Rheumatology conference presentation in 2020, Pediatric Rheumatologist Dr. Tamar Rubinstein estimated that “anxiety, depression, feeling suicidal, and other mental health events are likely around 30% for pediatric rheumatic diseases. These rates may be more than double than the general population.” 1

We also conducted focus groups on parent perspectives of our children’s mental health at our 2018 national family conference, the results of which were published in the Arthritis Care & Research Journal in January 2021. The conclusion states, “JM is associated with intense patient and family distress, although resiliency may emerge by young adulthood. Despite existing barriers, increasing access to counseling, peer support groups, and online resources with rheumatology facilitation may be effective intervention strategies.” 2

Click Here to Join Other JM Parents/Caregivers on FaceBook


“As a Pediatric Rheumatologist, I know that emotional and mental health are important to optimize overall health and integral in chronic conditions like JM. If you have concerns about your child’s emotional health that haven’t been addressed, please let your provider know so you can work together to get the needed help. Kudos to Cure JM for developing a position for a new Mental Health Coordinator to provide and develop more resources for this!”

Susan Kim, MD, MMSc
Pediatric Rheumatologist and Associate Clinical Professor of Pediatrics at UCSF Medical School sees patients in the Rheumatology Clinics at UCSF Benioff Children’s Hospitals San Francisco and Oakland sites.

Tratamientos asequibles y accesibles para la JM

Tratamientos asequibles y accesibles para la JM

Dos ponentes invitadas especiales, Michelle Vogel, MPA, IV Solutions RX, y Laurel Cherwin, BSN, RN, IgCN, Octapharma, compartieron información sobre cómo encontrar tratamientos asequibles y cuidados para pacientes con JM.

Decisión de la FDA sobre la vamorolona en la DMD

Es posible que haya oído hablar de la decisión de ayer de la FDA, que aprobó la vamorolona como esteroide alternativo para su uso en la distrofia muscular de Duchenne.

La vamorolona es una nueva alternativa a los corticoides con menos efectos secundarios que la prednisona. El fármaco pretende preservar las características beneficiosas antiinflamatorias y de fortalecimiento muscular de los corticosteroides, al tiempo que disminuye algunos de los efectos secundarios no deseados, como fragilidad ósea, retraso del crecimiento y cambios de comportamiento.

Como supimos en el anuncio de ayer, la vamorolona resultó ser segura y eficaz como terapia para la distrofia muscular de Duchenne en su nueva indicación aprobada.

Únete a Cure JM

La afiliación es gratuita y te pondremos en contacto con una red de apoyo, ánimo y recursos.

Cure JM apoya a las familias, los pacientes y la comunidad investigadora de la miositis juvenil.

¿Le interesa recaudar fondos por su cuenta pero necesita ayuda?

Estamos aquí para ayudarle.